NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Nu-Tek BioSciences

Nu-Tek BioSciences

Private
Minnetonka, MinnesotaHealthcare & Life Scienceshttps://nu-tekbiosciences.com/

Last Round

Early Funding

Oct 23, 2025

Total Funding Raised

$500,000

Company Overview

Nu-Tek BioSciences is a biotechnology company that develops and manufactures animal-free peptones and protein hydrolysates for the pharmaceutical and wellness food industries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Pharma Supply Chain

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

animal-origin-free peptonesprotein hydrolysatescell culture mediaAOF ingredientsbiopharmaceutical raw materialsindustrial fermentationyeast extractssoy peptonespea peptonesbiomanufacturing supply chainprocess optimizationvariability reduction programvegan mediaanimal-free biotechbiotech supply chain

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nu-Tek BioSciences Comparables

Compare Nu-Tek BioSciences with similar companies based on industry and business-model similarity.

Nu-Tek BioSciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Organotechnie SAS
77%
Global BioIngredients, Inc.
76%
Neomend
76%

Nu-Tek BioSciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingOct 23, 2025
Early FundingMay 1, 2024
DebtMar 3, 2021
GrantMar 3, 2021

Key People

Founding team and executive leadership

Thomas Yezzi

Chief Executive Officer

Executive Team

Nu-Tek BioSciences Investors

Notable investors and investment history

Nu-Tek BioSciences investors
InvestorRounds
Agent CapitalEarly Funding
Minnesota Department of Employment and Economic DevelopmentGrant, Debt
1315 CapitalEarly Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 3, 2026

    Monthly visitors grew 94% MoM, reaching 4.2K.

Nu-Tek BioSciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Nu-Tek BioSciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Nu-Tek BioSciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersMinnetonka, Minnesota
Employee Range27
Year Founded2008
Last FundingOct 23, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.